Fig. 1 · Structure

Documents & Downloads

TAK-779

Cat. No. A13846 CAS 229005-80-5

CCR5 antagonist

TAK-779 is a novel, potent and selective small-molecule antagonists of CCR5 with the IC50 value of 1.4nM in binding assay.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
MIP-1α-CCR5 1 nM (IC50, in CHO/CCR5 cells)
MIP-1β-CCR5 1 nM (IC50, in CHO/CCR5 cells)
RANTES-CCR5 1.4 nM (IC50, in CHO/CCR5 cells)
MCP-1-CCR2b 27 nM (IC50, in CHO/CCR5 cells)
R5 HIV-1 (Ba-L) 1.2 nM (EC50, in MAGI-CCR5 cells)
R5 HIV-1 (KK) 1.6 nM (EC50, in PBMCs)
R5 HIV-1 (HHA) 3.2 nM (EC50, in PBMCs)
R5 HIV-1 (CTV) 3.5 nM (EC50, in PBMCs)
R5 HIV-1 (Ba-L) 3.7 nM (EC50, in PBMCs)
R5 HIV-1 (Ba-L) 5.7 nM (EC90, in MAGI-CCR5 cells)
R5 HIV-1 (HHA) 7.5 nM (EC90, in PBMCs)
R5 HIV-1 (Ba-L) 12.8 nM (EC90, in PBMCs)
R5 HIV-1 (KK) 20.8 nM (EC90, in PBMCs)
R5 HIV-1 (CTV) 27 nM (EC90, in PBMCs)
mCXCR3 369 nM (IC50, in PBMCs)

15 targets · Scroll to view more

Cellular Effect

Cell Line Activity Value Description Reference
HEK-293T EC50 7 nM Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay [PMID: 28463783]
MOLT-4 IC50 7.9 nM Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry [PMID: 21820898]
PC-3 IC50 37.85 μM Antiproliferative activity against human PC3 cells after 72 hrs by WST-1 assay [PMID: 24731275]
U2OS IC50 23 μM Antagonist activity against mouse CCR2B expressed in human U2OS cells co-expressing beta-arrestin assessed as inhibition of mouse CCL2-induced beta-arrestin recruitment pre-incubated for 10 mins before mouse CCL2 stimulation for 90 mins by luminescence ba [PMID: 25766632]
U2OS IC50 6 nM Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measure [PMID: 31742400]

Specifications

Manufacturer Adooq Bioscience
Actions Antagonist
CAS Number 229005-80-5
Applications CCR5 antagonist
Formula C33H39N2O2.Cl
Molecular Weight 531.136
SMILES
CC1=CC=C(C=C1)C2=CC3=C(CCCC(=C3)C(=O)NC4=CC=C(C=C4)C[N+](C)(C)C5CCOCC5)C=C2.[Cl-]

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...